Vascular endothelial growth factor expression in preoperative biopsy specimens correlates with disease recurrence in patients with early gastric carcinoma

Cancer

Volumn 86, Issue 4, 1999, Pages 566-571

  Maeda, Kiyoshi ^a   Kang, Soon Myoung ^a   Onoda, Naoyoshi ^a   Ogawa, Masafumi ^a   Kato, Yasuyuki ^a   Sawada, Tetsuji ^a   Chung, Kosei Hirakawa Yong Suk ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Early gastric carcinoma; Prognostic factor; Tumor angiogenesis; Vascular endothelial growth factor

Indexed keywords

ENDOTHELIAL CELL GROWTH FACTOR;

ADULT; AGED; ANGIOGENESIS; ARTICLE; EARLY DIAGNOSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECURRENT DISEASE; STOMACH CARCINOMA; TREATMENT OUTCOME; TUMOR BIOPSY; TUMOR VOLUME;

ADULT; AGED; ENDOTHELIAL GROWTH FACTORS; FEMALE; GENES, P53; HUMANS; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033566969     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990815)86:4<566::AID-CNCR4>3.0.CO;2-1     Document Type: Article

References (24)

1. Sawai K, Takahashi T, Suzuki H. New trends in surgery for gastric cancer in Japan. J Surg Oncol 1994;56:221-6.
2. Ichiyoshi Y, Toda T, Minamisono Y, Nagasaki S, Yakeishi Y, Sugimachi K. Recurrence in early gastric cancer. Surgery 1990;107:489-95.
3. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y, et al. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 1995;13:477-81.
4. Maeda K, Chung YS, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y, et al. Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma. Br J Cancer 1995;72:319-23.
5. Ogawa M, Maeda K, Onoda N, Chung YS, Sowa M. Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma. Br J Cancer 1997;75:1617-20.
6. Maeda K, Ogawa M, Chung YS, Kang SM, Sawada T, Onoda N, et al. Overexpression of p53 associated with tumor angiogenesis, tumor cell proliferation, and prognosis in gastric carcinoma. Oncol Rep 1997;4:765-8.
7. Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 1992;84:1875-87.
8. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
9. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996;77:858-63.
10. Kakeji K, Maehara Y, Tomoda M, Kabashima A, Ohmori M, Oda S, et al. Long term survival of patients with stage IV gastric carcinoma. Cancer 1998;82:2307-11.
11. Martin H, Filipe M, Morris R, Lane D, Silvestre F. p53 expression and prognosis in gastric carcinoma. Int J Cancer 1993;50:859-62.
12. Robbins BA, De la Vega D, Ogata K, Tan EM, Nakamura RM. Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies. Arch Pathol Lab Med 1987;11:841-5.
13. Japanese Research Society for Gastric Cancer. Japanese classification of gastric carcinoma. First English Ed. Tokyo: Kanehara & Co., Ltd., 1993.
14. Inoue M, Okayama A, Fujita M, Enomoto T, Sakata M, Tanizawa O, et al. Clinicopathological characteristics of p53 overexpression in endometrial cancers. Int J Cancer 1994; 58:14-9.
15. Cox DR. Regression models and life tables. J R Stat Soc [B] 1972;34:187-220.
16. Shiozawa N, Kodama M, Chida T, Arakawa A, Tur GE, Koyama K. Recurrent death among early gastric cancer patients: 20-years experience. Hepatogastroenterology 1994;41: 244-7.
17. Sano T, Kobori O, Muto T. Lymph node metastasis from early gastric cancer: endoscopic resection of tumour. Br J Surg 1992;79:241-4.
18. Dvorak HF, Siossat TM, Brown LF, Berse B, Nagy JA, Sotrel A, et al. Distribution of vascular permeability factors in tumors: concentration in tumor blood vessels. J Exp Med 1991;174:1275-8.
19. Toi M, Hoshina S, Takayanagi T, Tominaga T. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast carcinoma. Jpn J Cancer Res 1994;85:1045-9.
20. Takahashi Y, Kitadai Y, Bucana CD, Cleary KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1996;55: 3964-8.
21. Takemoto T, Tada M. Significance of strip biopsy with particular reference to endoscopic "mucosectomy". Dig Endosc 1989;1:4-10.
22. Yamaoka M, Yamamoto T, Makaki T, Ikeyama S, Suso K, Fujita T. Inhibition of tumour growth and metastasis of rodent tumours by the angiogenesis inhibitor o-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470). Cancer Res 1993;53:4262-7.
23. Kim KJ, Li B, Winer J, Aramani M, Gillett N, Phillips HS, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993; 362:841-4.
24. O'Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med 1996;2:686-92.